Speaker(s): 

Thomas P. Olenginski, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1)  Recognize ongoing gaps in osteoporosis care

2)  Illustrate the system-based value of risk group reporting within Geisinger DXA Services

3)   Appraise our continued efforts at secondary fracture prevention

4)  Apply limits on bisphosphonate usage (Risk/Reward)

5)  Utilize Trabecular Bone Score (TBS) in assessment of risk

6)   Demonstrate yourself to discuss ONJ and AFF in clinical care

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None